Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Cancer Research
|
January 1, 1995
Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas
D G Walker, W Duan, E A Popovic, et al.
Journal of Neurosurgery
|
March 1, 1984
Intracranial extension of inflammatory pseudotumor of the orbit. Case report
A H Kaye, J F Hahn, A Craciun, et al.
British Journal of Cancer
|
March 1, 1992
Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy
K W Woodburn, S Stylli, J S Hill, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 25, 2016
The emergent role of exosomes in glioma
J Gourlay, A P Morokoff, R B Luwor, et al.
Neurosurgery
|
February 1, 1990
Selective uptake of hematoporphyrin derivative into human cerebral glioma
J S Hill, A H Kaye, W H Sawyer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 1995
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer
J S Hill, S B Kahl, S S Stylli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1983
The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues
P C Tagari, A H Kaye, P J Teddy, et al.
British Journal of Cancer
|
September 1, 1994
Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy
K W Woodburn, J S Hill, S Stylli, et al.
Journal of Neurosurgery
|
May 1, 1984
CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients
A H Kaye, P C Tagari, P J Teddy, et al.
Photochemistry and Photobiology
|
May 1, 1992
Evaluation of porphyrin characteristics required for photodynamic therapy
K W Woodburn, N J Vardaxis, J S Hill, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Cancer Research
|
January 1, 1995
Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas
D G Walker, W Duan, E A Popovic, et al.
Journal of Neurosurgery
|
March 1, 1984
Intracranial extension of inflammatory pseudotumor of the orbit. Case report
A H Kaye, J F Hahn, A Craciun, et al.
British Journal of Cancer
|
March 1, 1992
Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy
K W Woodburn, S Stylli, J S Hill, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 25, 2016
The emergent role of exosomes in glioma
J Gourlay, A P Morokoff, R B Luwor, et al.
Neurosurgery
|
February 1, 1990
Selective uptake of hematoporphyrin derivative into human cerebral glioma
J S Hill, A H Kaye, W H Sawyer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 1995
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer
J S Hill, S B Kahl, S S Stylli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1983
The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues
P C Tagari, A H Kaye, P J Teddy, et al.
British Journal of Cancer
|
September 1, 1994
Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy
K W Woodburn, J S Hill, S Stylli, et al.
Journal of Neurosurgery
|
May 1, 1984
CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients
A H Kaye, P C Tagari, P J Teddy, et al.
Photochemistry and Photobiology
|
May 1, 1992
Evaluation of porphyrin characteristics required for photodynamic therapy
K W Woodburn, N J Vardaxis, J S Hill, et al.
Page
of 11